Hypopharyngeal Carcinoma

subtype

Identifier: CI-CAN-00007833
Entity page: /cancer/hypopharyngeal-carcinoma ↗
Edges: 194

Neighbours: 15 drugs10 trials
Drawn: 25 of 25 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Hypopharyngeal Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 48show all (up to 200)
→ investigated in trials for	Cisplatinsmall molecule 35 trials (12 active) · roll-up of the cancer and its descendants	—	—	Hypopharyngeal Carcinoma	35	Observed	clinicaltrials	graph →
→ investigated in trials for	Cetuximabmonoclonal antibody

Hypopharyngeal Carcinoma studied in …STUDIED_INderived10 of 146show all (up to 200)
→ studied in	NCT06589804Phase 3 · recruiting Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment · condition mapped CURATED_BROADER · 146 trials mapped (51 active)	—	—	Hypopharyngeal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05136196Phase 2 · recruiting BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study · condition mapped CURATED_BROADER · 146 trials mapped (51 active)	—	—	Hypopharyngeal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06980038Phase 2 · recruiting Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 146 trials mapped (51 active)	—	—	Hypopharyngeal Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04671667Phase 2 · recruiting Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 146 trials mapped (51 active)	—	—	Hypopharyngeal Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05172245Phase 1 · recruiting Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer · condition mapped CURATED_BROADER · 146 trials mapped (51 active)	—	—	Hypopharyngeal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05172258Phase 2 · active not recruiting Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck · condition mapped CURATED_BROADER · 146 trials mapped (51 active)	—	—	Hypopharyngeal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02734537Phase 2 · recruiting Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery · condition mapped CURATED_BROADER · 146 trials mapped (51 active)	—	—	Hypopharyngeal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05721755Phase 3 · active not recruiting Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck · condition mapped CURATED_BROADER · 146 trials mapped (51 active)	—	—	Hypopharyngeal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05752149Phase 2 · recruiting Fluorescence-guided Surgery in Laryngeal- and Hypopharyngeal Cancer: a Feasibility Trial · condition mapped ALIAS · 146 trials mapped (51 active)	—	—	Hypopharyngeal Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07156227Phase 1 · recruiting Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 146 trials mapped (51 active)	—	—	Hypopharyngeal Carcinoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains